Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo

The term apoptosis was proposed to define a type of cell death morphologically, biochemically, and molecularly distinct from necrosis, which plays a fundamental regulatory function in the control of the overall size of cell populations, being complementary but opposite to cell proliferation [Kerr et al. (1972): Br J Cancer 26:239–257]. This view has led to the appreciation that apoptosis is an integral part of normal biological processes and may impact on disease states. Introduction of the concept of apoptosis has raised great interest and many studies have been aimed to the identification of genes responsible for the induction of cell death. Indeed, over the past few years, many genes whose expression is associated with cell death have been described, and the molecular mechanisms underlying cell death have been, in some circumstances, clearly established. However, it is now evident that extension of the conclusions achieved by studies performed with highly selected in vitro systems (simple systems), to in vivo conditions (complex systems), has generated a certain degree of confusion. This is in part due to the indiscriminate use of the term apoptosis and to the uncertainty whether apoptosis is always different from necrosis, and, if this is the case, to the lack of well established criteria to discriminate the two processes; in addition, in addition, it still remains to be established whether both types of cell death, although different, could be induced simultaneously by the same agent, depending on the cell type and the experimental condition used. The distinction between apoptosis and necrosis, is not simply a problem of terminology; if necrosis and apoptosis are different from a mechanistic point of view, and if necrosis is merely the passive result of cellular injury (still to be shown), it becomes critical to discriminate between the two processes, in order to understand how to modulate apoptosis in view of its potential therapeutic use. This review will summarize existing informations and discuss some of the conflicting issues related to cell death in the liver.

[1]  A. Nègre-Salvayre,et al.  Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium‐dependent pathways in lymphoblastoid cells , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  R. Schwall,et al.  Induction of apoptosis in the murine liver with recombinant human activin a , 1994, Hepatology.

[3]  Y. Dragan,et al.  Biochemical events during initiation of rat hepatocarcinogenesis. , 1994, Carcinogenesis.

[4]  E Farber,et al.  Programmed cell death: necrosis versus apoptosis. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[5]  P. Gaulard,et al.  Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. , 1994, The American journal of pathology.

[6]  A. Columbano,et al.  Cell proliferation and cell death in rat liver carcinogenesis by chemicals. , 1994, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[7]  J. Farber,et al.  Microtubule antagonists activate programmed cell death (apoptosis) in cultured rat hepatocytes. , 1993, The American journal of pathology.

[8]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[9]  L. Dini,et al.  Galactose-specific receptor modulation related to the onset of apoptosis in rat liver. , 1993, European journal of cell biology.

[10]  R. L. Hall,et al.  Expression of TRPM-2 during involution and regeneration of the rat liver. , 1993, Cancer letters.

[11]  R. Lockshin,et al.  Delayed internucleosomal DNA fragmentation in programmed cell death , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  J. Chiu,et al.  Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis? , 1993, The American journal of pathology.

[13]  D. Vaux Toward an understanding of the molecular mechanisms of physiological cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  I. Weissman,et al.  Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. , 1992, Science.

[15]  John Calvin Reed,et al.  Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Bursch,et al.  Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. M. Ledda-Columbano,et al.  Rapid induction of apoptosis in rat liver by cycloheximide. , 1992, The American journal of pathology.

[18]  L. Fésüs,et al.  Apoptosis: molecular mechanisms in programmed cell death. , 1991, European journal of cell biology.

[19]  G. M. Ledda-Columbano,et al.  Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. , 1991, The American journal of pathology.

[20]  S. Korsmeyer,et al.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Bursch,et al.  Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. , 1991, Cancer research.

[22]  R. Lieberman,et al.  Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E G Luebeck,et al.  Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen. , 1990, Carcinogenesis.

[24]  H. Horvitz,et al.  The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. , 1990, Developmental biology.

[25]  N. Kyprianou,et al.  Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death , 1989 .

[26]  A. Columbano,et al.  Cell deletion by apoptosis during regression of renal hyperplasia. , 1989, The American journal of pathology.

[27]  L. Gaspa,et al.  Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis. , 1989, Cancer research.

[28]  G I Bell,et al.  Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Falus,et al.  Induction and activation of tissue transglutaminase during programmed cell death , 1987, FEBS letters.

[30]  A. Columbano,et al.  Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. , 1987, Cancer research.

[31]  D. Sarma,et al.  Hepatocarcinogenesis: a dynamic cellular perspective. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[32]  M. Alison Regulation of hepatic growth. , 1986, Physiological reviews.

[33]  P. Bhathal,et al.  Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus. , 2008, Liver.

[34]  W. Bursch,et al.  Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[35]  G. M. Ledda-Columbano,et al.  Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[36]  G. M. Ledda-Columbano,et al.  Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. , 1984, The American journal of pathology.

[37]  W. Bursch,et al.  Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. , 1984, Carcinogenesis.

[38]  T. Anderson,et al.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. , 1981, British Journal of Cancer.

[39]  A. Columbano,et al.  Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. , 1981, Cancer research.

[40]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[41]  J. Popp,et al.  The protective effects of diethyldithiocarbamate and cycloheximide on the multiple hepatic lesions induced by carbon tetrachloride in the rat. , 1978, Toxicology and applied pharmacology.

[42]  C. Potten,et al.  Extreme sensitivity of some intestinal crypt cells to X and γ irradiation , 1977, Nature.

[43]  D. Levison,et al.  Atrophy and apoptosis in the cyclical human endometrium , 1976, The Journal of pathology.

[44]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[45]  R. Lockshin Programmed cell death. Activation of lysis by a mechanism involving the synthesis of protein. , 1969, Journal of insect physiology.